Schedule your COVID-19 vaccine wherever possible. Please do not call your doctor as they cannot schedule an appointment for you. Learn more.

Scripps Oncologist Discusses New Cancer Study on KUSI

Randev Konijeti, MD, focuses on prevention

Scripps oncologist Randev Konijeti, MD, discusses new study on KUSI

From left, KUSI anchor Ginger Jeffries and Scripps urologic oncology surgeon Ramdev Konijeti, MD.

Randev Konijeti, MD, focuses on prevention

Ramdev Konijeti, MD, an oncology surgeon at Scripps Clinic, recently discussed cancer prevention strategies with KUSI.

Dr. Konijeti was invited to comment on a new study by the American Cancer Society. The study found that about 40 percent of new cancer cases in the nation were linked to modifiable risk factors, and could have been prevented.

View the segment on KUSI: New Cancer Prevention Study

Media Contact

Stephen Carpowich
Follow me: @Carpowich